Ron Martin, a consummate newspaperman credited with setting the tone at USA TODAY as the newspaper’s first executive editor, died Saturday.
Author: Elizabeth Weise, USA TODAY
Abortion by pill figures to rise if Supreme Court overturns Roe v. Wade
Abortion by pill is used to terminate at least 54% of pregnancies in the U.S., a number expected to rise even higher if Roe v Wade is overturned.
Punishing heat wave in India reaches 115 degrees, part of a ‘hotter and more dangerous world’
A month-long heatwave across Asia is pushing temperatures in India as high as 115 degrees. Such heatwaves will be more common, experts say.
Could eating bug powder and fungus meat help fight climate change? Yes, but there are easier ways.
“Novel or future foods,” including vat-grown meat and culture-grown milk, could play a key role in reducing climate impact, according to a new study.
‘A year after year disaster:’ The American West could face a ‘brutal’ century under climate change
Models show the American West faces more fires, floods and air pollution this century if meaningful climate action isn’t taken soon.
Extreme heat already disrupts air travel: With climate change, it’s going to get worse
As the planet warms, extreme heat disruptions to airplanes, previously only known in the world’s hottest areas, are expected to become more commonplace.
Electric cars coming on fast: Climate worries, sinking prices put spotlight on EV sales
Climate change means more vehicles will have to be electric. American are increasingly choosing them because they’re cheap to run and fun to drive.
Here comes the sun: Wind, solar power account for record 13% of U.S. energy in 2021
Solar and wind energy last year grew at the fastest rate in U.S. history and now account for a record 13% of U.S. power generation, according to a report released Thursday.
Winds of change: 6 companies bid record $4.37B for offshore leases in New York, New Jersey
Six companies have agreed to pay a record-breaking $4.37 billion for the right to build wind turbines off the coasts of New York and New Jersey.
‘Not typical’: FDA takes unusual step in urging Pfizer to seek approval for child vaccine
In a move that highlights rising concerns about the risks of COVID-19 to young children, Pfizer asked for federal OK for its vaccine for children.